SeNPs were shown to activate tumor suppressor pathways, such as p53, promote the expression of pro-apoptotic proteins (Bax, caspase-3, caspase-9), and suppress anti-apoptotic proteins (Bcl-2), inducing programmed cell death [14,77]. The gene discussed is CASP3; the disease is neoplasm.